0

l-Glutamine for Sickle Cell Anemia: More Questions Than Answers

Charles T Quinn

Blood. 2018 Aug 16;132(7):689-693.

PMID: 29895661

Abstract:

In 2017, the Food and Drug Administration approved 2 medications for sickle cell anemia (SCA): hydroxyurea for children and l-glutamine for children and adults. The approval of hydroxyurea was long overdue, but the approval of l-glutamine was a surprise to many. Any effective new treatment for SCA is a welcome advance, but there are few published studies of l-glutamine as a specific treatment for SCA. Accordingly, there are many unanswered questions about its efficacy, safety, and role in current therapy.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
AP80143573 L-Glutamine-(amine-15N) L-Glutamine-(amine-15N) 80143-57-3 Price
qrcode